4 hours ago 2

Children's Hospital of Philadelphia Cancer Researchers Elected to the 2025 Class of Fellows of the AACR Academy

Garrett M. Brodeur and Stephan A. Grupp to be honored at AACR's Annual Meeting

, /PRNewswire/ -- Children's Hospital of Philadelphia (CHOP) is honored to announce that distinguished cancer researchers Garrett M. Brodeur, MD, and Stephan A. Grupp, MD, PhD, have been elected to the 2025 class of Fellows of the American Association for Cancer Research (AACR) Academy.

Dr. Stephan Grupp, Inaugural Director of the Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy at Children's Hospital of Philadelphia

Dr. Stephan Grupp, Inaugural Director of the Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy at Children's Hospital of Philadelphia

Dr. Garrett Brodeur, Director of the Cancer Predisposition Program at Children's Hospital of Philadelphia

Dr. Garrett Brodeur, Director of the Cancer Predisposition Program at Children's Hospital of Philadelphia

Each year, the Fellows of the AACR Academy recognizes and honors extraordinary scientists whose groundbreaking contributions have driven significant innovation and progress in the fight against cancer. Fellows of the AACR Academy constitute a global brain trust of leading experts in cancer communication, advocacy, and funding for cancer research.

Dr. Brodeur, Director of the Cancer Predisposition Program at CHOP, and Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, is being recognized for his invaluable contributions to neuroblastoma research, such as identifying MYCN amplification as a marker of high-risk disease; leading efforts to develop the first International Neuroblastoma Staging System and Risk Grouping that incorporates molecular markers and preclinical development of TRK inhibitors for pediatric solid tumors; organizing pioneering international workshops on pediatric cancer predisposition and surveillance; and developing a novel multivalent nanomedicine (PEEL-24) that is more effective and less toxic than its conventional counterpart, irinotecan.

Dr. Grupp, Section Chief of the Cellular Therapy and Transplant Section, Inaugural Director of the Kelly Center for Cancer Immunotherapy at CHOP, and Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, is being recognized for exemplary research efforts leading to the development of chimeric antigen receptor-modified T-cell (CAR T-cell) therapy in pediatric patients, thereby revolutionizing personalized cancer treatment and leading to the FDA approval of tisagenlecleucel for B-cell acute lymphoblastic leukemia, the first CART-cell and gene therapy approved for use in patients. Dr. Grupp also holds the Yetta Deitch Novotny Endowed Chair in Pediatric Oncology at CHOP.

Fellows of the AACR are nominated and elected through a meticulous, multistep, peer-reviewed process that rigorously evaluates each candidate's scientific achievements and contributions to the global cancer research community. Only those who work has made a profound and lasting impact on cancer research and related fields are considered for election and induction into the AACR Academy.

The Class of 2025 has elected 33 new Fellows into the AACR Academy, bringing the total number of Fellows to 375. Drs. Brodeur and Grupp will be formally inducted at this year's AACR Annual Meeting held April 25-30 in Chicago, Illinois.

Learn more about the Fellows of the AACR Academy at: https://www.aacr.org/professionals/membership/aacr-academy/.

About Children's Hospital of Philadelphia:  

A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey, as well as the Middleman Family Pavilion and its dedicated pediatric emergency department in King of Prussia. In addition, its unique family-centered care and public service programs have brought Children's Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit https://www.chop.edu. 

Contact: Jennifer Lee
Children's Hospital of Philadelphia
267-426-6084
[email protected]

SOURCE Children's Hospital of Philadelphia

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Digital Media
Outlets

icon2

270k+
Journalists
Opted In

Read Entire Article

From Twitter

Comments